07/01/2022
Clario is pleased to welcome our new CEO, Christopher Fikry, M.D.
Chris’ tenure begins today, July 1, 2022, as his predecessor, Joe Eazor, transitions to a seat on the Clario Board of Directors.
Chris brings decades of industry experience to his role as leader of the company as well as enthusiasm to continue Clario’s growth trajectory.
Initial commitments from Chris include increased collaboration with both customers and employees, leveraging Clario’s technology and scientific expertise to shape the future of medicine and medical device development.
“Clario is fueled by a culture of excellence and I am honored to lead the company as it continues to provide best-in-class customer service and technologies that have a tangible positive impact on our customers’ goals and ultimately patients' lives,” said Christopher Fikry, M.D. as he steps into the CEO role at Clario.
Learn more about Chris and how this leadership change will benefit Clario customers by reading today’s press release announcing the event:
Christopher Fikry, M.D. begins his tenure at Clario CEO